Projects per year
Personal profile
Education
Ph.D., National Yang Ming Chiao Tung University,Taiwan
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Wei Teng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
An Investigation into the Role and Underlying Mechanisms of Innate-Like T Cells in Hcc Patients Receiving Immune Checkpoint Inhibitors by Single Cell Approach
Teng, W. (PI) & Lin, C.-Y. (CoPI)
01/08/24 → 31/07/25
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Utilizing Multi-Omics Approach to Investigate the Association between Hbv Quasispecies and Host Antiviral Immune Phenotype Along with Their Impacts on Clinical Outcome and Treatment Efficacy
Jeng, W.-J. (PI), Huang, C. H. (CoPI), Lin, C.-Y. (CoPI), Lin, P. T. (CoPI), Teng, W. (CoPI) & Yang, H. I. (CoPI)
01/08/24 → 31/07/25
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Hepatocellular carcinoma systemic treatment update: From early to advanced stage
Teng, W., Wu, T. C. & Lin, S. M., 2025, (Accepted/In press) In: Biomedical Journal. p. 100815 100815.Research output: Contribution to journal › Journal Article › peer-review
Open Access1 Citation (SciVal) -
Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis
Hsu, Y. C., Lin, P. T., Teng, W., Hsieh, Y. C., Chen, W. T., Su, C. W., Wang, C. T., Chai, P. M., Lin, C. C., Lin, C. Y. & Lin, S. M., 12 10 2024, In: Cancers. 16, 20, 3458.Research output: Contribution to journal › Journal Article › peer-review
Open Access4 Scopus citations -
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma
Su, C. W., Teng, W., Shen, E. Y. L., Huang, B. S., Lin, P. T., Hou, M. M., Wu, T. H., Tsan, D. L., Hsieh, C. H., Wang, C. T., Chai, P. M., Lin, C. Y., Lin, S. M. & Lin, C. C., 05 07 2024, In: Oncologist. 29, 7, p. e922-e931Research output: Contribution to journal › Journal Article › peer-review
Open Access5 Scopus citations -
Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines
Teng, W., Chang, T., Yang, H., Peng, C., Su, C., Su, T., Hu, T., Yu, M., Yang, H. & Wu, J., 06 2024, In: Hepatology International. 18, 3, p. 1066 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for Oligoprogression
Liu, T. H., Chen, S. C., Rau, K. M., Lu, L. C., Lin, P. T., Su, Y. Y., Teng, W., Lai, S. W., Yeh, R. H., Kao, T. M., Lee, P. C., Wu, C. J., Chen, C. H., Hsu, C. H., Lin, S. M., Huang, Y. H., Chen, L. T., Cheng, A. L. & Shen, Y. C., 01 02 2024, In: Liver Cancer. 13, 5, p. 509-521 13 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access1 Scopus citations